ALEXANDRIA, Va. – Co-sponsors of the 2018 Genitourinary Cancers Symposium announced today four abstracts to be highlighted in the meeting’s official Press Program. Researchers will present the findings of these studies in an embargoed presscast for reporters, taking place Monday, February 5, 2018, from 12:00 noon – 1:30 p.m. ET.
ALEXANDRIA, Va. — CancerLinQ LLC and the National Society of Genetic Counselors (NSGC), the professional society for genetic counselors, announced today that they have entered into a strategic alliance. With the collaboration, NSGC leaders and members will provide expertise to CancerLinQ®, the American Society of Clinical Oncology’s (ASCO) health information technology platform aimed at improving the quality of cancer care using real-world cancer data.
With the Tax Cuts and Jobs Act on the verge of being signed into law, the American Society of Clinical Oncology (ASCO) is concerned about across-the-board cuts to Medicare that the measure will trigger. We urge Congress to protect Medicare beneficiaries with cancer and other medical conditions by passing additional legislation to avoid cuts to the program.
ALEXANDRIA, Va. — CancerLinQ LLC and the data services companies Tempus and Precision HealthAI announced today they have entered into an agreement that will accelerate development and delivery of high-quality, de-identified clinical databases for use by CancerLinQ®, its oncologist subscribers, partners, and the broader cancer community. The agreement will also enable CancerLinQ to more quickly build and expand on its core data sharing and quality improvement platform for oncology practices, and facilitate Tempus’ and Precision HealthAI’s connection to industry to support faster and better development of new treatments for patients.
Howard A. “Skip” Burris III, MD, FACP, FASCO, a long-time member and volunteer, has been elected to serve as the President of the American Society of Clinical Oncology (ASCO) for the term beginning in June 2019. Additionally, five members were elected to open seats on the ASCO Board of Directors, as well as two members to the ASCO Nominating Committee.
ALEXANDRIA, Va. -- CancerLinQ LLC and DIA, (Drug Information Association), a global nonprofit association of health care product development professionals, announced today that they have entered into a programmatic partnership. Under the agreement, DIA will offer the scientific expertise of its members from the life sciences industry to help inform CancerLinQ’s development and rollout. CancerLinQ® is ASCO’s health information technology platform, developed by oncologists for oncologists, aimed at enhancing and improving the understanding and treatment of cancer.
We are deeply concerned about the sequestration cuts that would be triggered by passage of the Tax Cuts and Jobs Act. The core mission of the American Society of Clinical Oncology (ASCO) is to ensure that cancer patients have meaningful access to high-quality cancer care. We fear that the current proposal will harm patients with cancer by reducing access to care, a situation that could adversely impact treatment needed to extend and save patients' lives.
A report released today by the National Academies of Sciences, Engineering, and Medicine underscores the imperative our nation faces to address the affordability of drugs for medical conditions that have long-been deemed untreatable. Nowhere is this imperative more urgent than with the new generation of cancer drugs that is giving hope to the millions of Americans who face a cancer diagnosis each year--while creating formidable barriers to access due to the high cost of these agents.
A new Physician Assistant (PA)-based study finds that despite personal satisfaction in the oncology specialty, high rates of burnout –over one third of PAs (34.8%)—are common. These findings reveal important factors that could help to decrease burnout and improve the oncology workforce dynamics, including the relationship between PAs, collaborating physicians, and the care team. The study was published today in the Journal of Oncology Practice (JOP).
Patricia A. Ganz, MD, FASCO, is the 2018 recipient of the Ellen L. Stovall Award and Lecture for Advancement of Cancer Survivorship Care.
ALEXANDRIA, Va. -- The American Society of Clinical Oncology’s (ASCO) Targeted Agent and Profiling Utilization Registry (TAPUR) Study has expanded four cohorts for enrollment of additional participants and continues to grow with more than 500 participants and 16 therapies now available.
Alcohol use—whether light, moderate, or heavy—is linked with increasing the risk of several leading cancers, including those of the breast, colon, esophagus, and head and neck, according to evidence gathered by the American Society of Clinical Oncology (ASCO).
ALEXANDRIA, Va. – Recommendations from an American Society of Clinical Oncology (ASCO) “Summit on Addressing Obesity through Multidisciplinary Collaboration” have been published in a new article in Obesity. The recommendations cover four key areas in response to the current issues providers face in addressing obesity prevention and treatment and its impact on morbidity and mortality in the United States.
SAN DIEGO – Five studies exploring noteworthy issues in palliative care will be presented at the 2017 Palliative and Supportive Care in Oncology Symposium, taking place October 27-28 at the Manchester Grand Hyatt in San Diego, California. These key abstracts explore several approaches for improving quality of life and quality of care for people with cancer, as well as survivors of cancer.
ALEXANDRIA, Va. – The majority of Americans are unaware of several major risk factors for cancer – most notably obesity, which will soon overtake smoking as the largest preventable cause of cancer in the United States. High treatment costs are compromising care: one in four people who have had cancer or have an immediate family member who has had cancer are forgoing treatment or physician visits because of the expense. In addition, nearly three-quarters of Americans support greater federal investment in cancer research, even if it means higher taxes or adding to the deficit. These are a few of the many findings from the American Society of Clinical Oncology (ASCO)’s National Cancer Opinion Survey, a large, nationally representative survey conducted online by Harris Poll.